Mechanical Ventilation in Patients with End-Stage Idiopathic Pulmonary Fibrosis

被引:70
|
作者
Mollica, Corrado [2 ]
Paone, Gregorino [1 ,6 ]
Conti, Vittoria [1 ]
Ceccarelli, Daniela [1 ]
Schmid, Giovanni [6 ]
Mattia, Paolo [3 ]
Perrone, Nicola [4 ]
Petroianni, Angelo [1 ]
Sebastiani, Alfredo [2 ]
Cecchini, Luca [2 ]
Orsetti, Remo [5 ]
Terzano, Claudio [1 ]
机构
[1] Univ Roma La Sapienza, Dept Cardiovasc & Resp Sci, Rome, Italy
[2] S Camillo Forlanini Hosp, Resp Intermediate Intens Care Unit, Rome, Italy
[3] S Camillo Forlanini Hosp, Radiol Unit, Rome, Italy
[4] S Camillo Forlanini Hosp, Unit Pulm Physiopathol, Rome, Italy
[5] S Camillo Forlanini Hosp, Intens Care Unit, Rome, Italy
[6] Don Gnocchi Fdn S Maria Della Pace, Rome, Italy
关键词
Acute respiratory failure; Idiopathic pulmonary fibrosis; Invasive mechanical ventilation; Non-invasive mechanical ventilation; POSITIVE-PRESSURE VENTILATION; ACUTE RESPIRATORY-FAILURE; INTENSIVE-CARE-UNIT; NONINVASIVE VENTILATION; LUNG; DISEASE; HELMET;
D O I
10.1159/000225932
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Acute respiratory failure (ARF) occurring during idiopathic pulmonary fibrosis (IPF) is associated with a poor prognosis. In this subset of individuals, mechanical ventilation (MV) may be required. Objectives: We analysed the characteristics of a group of IPF patients undergoing MV for ARF in order to give some indications on the supposed prognosis. Methods: Hospital records of 34 consecutive patients with IPF, who underwent MV for ARF, were retrospectively examined. Demographic data, time from diagnosis, gas exchange, Acute Physiology and Chronic Health Evaluation (APACHE) II score, ARF causes and MV failure were recorded. Results: Fifteen subjects (group A) underwent invasive MV and 19 patients (group B) non-invasive ventilation (NIV). The 2 groups were different for disease severity (APACHE II score 24.2 +/- 6 vs. 19.5 +/- 5.9; p = 0.01). Both ventilatory strategies temporarily increased PaO2/FiO(2) as compared with spontaneous breathing (group A: 148.5 +/- 52 vs. 99 +/- 39, p = 0.0004; group B: 134 +/- 36 vs. 89 +/- 26, p = 0.0004). NIV reduced the respiratory rate (26 +/- 7 vs. 36 +/- 9 with spontaneous breathing; p = 0.002). Duration of MV correlated with the time of evolution of IPF (r = 0.45; p = 0.018). The in-hospital mortality rate was 85% (100% for invasive MV, 74% for NIV). Four of the 5 survivors died within 6 months from hospital discharge (range 2-6 months). Conclusions: MV does not appear to have a significant impact on the survival of patients with end-stage IPF. NIV may be useful for compassionate use, providing relief from dyspnoea and avoiding aggressive approaches. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:209 / 215
页数:7
相关论文
共 50 条
  • [1] Severity of Illness and Outcome in Patients With End-Stage Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation
    Paone, Gregorino
    Mollica, Corrado
    Conti, Vittoria
    Vestri, Annarita
    Cammarella, Ilio
    Lucantoni, Gabriele
    Leone, Alvaro
    Terzano, Claudio
    [J]. CHEST, 2010, 137 (01) : 241 - 242
  • [2] Severity of Illness and Outcome in Patients With End-Stage Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation Response
    Fernandez-Perez, Evans R.
    Gajic, Ognjen
    [J]. CHEST, 2010, 137 (01) : 242 - 242
  • [3] Clinical Evaluation of Lung Transplantation for End-Stage Idiopathic Pulmonary Fibrosis Patients with Lung Cancer
    Zhang, J.
    Liu, D.
    Chen, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1142 - 1142
  • [4] Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis
    Kitsios, Georgios D.
    Rojas, Mauricio
    Kass, Daniel J.
    Fitch, Adam
    Sembrat, John C.
    Qin, Shulin
    Veraldi, Kristen L.
    Gibson, Kevin F.
    Lindell, Kathleen
    Pilewski, Joseph M.
    Methe, Barbara
    Li, Kelvin
    McDyer, John
    McVerry, Bryan J.
    Morris, Alison
    [J]. THORAX, 2018, 73 (05) : 481 - 484
  • [5] "End-Stage" Pulmonary Fibrosis in Sarcoidosis
    Teirstein, Alvin T.
    Morgenthau, Adam S.
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2009, 76 (01): : 30 - 36
  • [6] Ca 19-9 serum levels in patients with end-stage Idiopathic Pulmonary Fibrosis (IPF)
    Balestro, Elisabetta
    Cocconcelli, Elisabetta
    Biondini, Davide
    Fracasso, Federico
    Castelli, Gioele
    Marulli, Giuseppe
    Rea, Federico
    Cosio, Manuel G.
    Saetta, Marina
    Spagnolo, Paolo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [7] Pulmonary arterial hypertension in end-stage Idiopathic pulmonary fibrosis: a hypothetic role for viral infections
    Lunardi, F.
    Balestro, E.
    Cuffaro, G.
    Nordio, B.
    Rossi, E.
    Loy, M.
    Saetta, M.
    Valente, M.
    Rea, F.
    Calabrese, F.
    [J]. VIRCHOWS ARCHIV, 2010, 457 (02) : 162 - 162
  • [8] Home ventilation for patients with end-stage chronic obstructive pulmonary disease
    Raveling, Tim
    Rantala, Heidi A.
    Duiverman, Marieke L.
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (04) : 277 - 282
  • [9] TRACTION BRONCHIECTASIS IN END-STAGE PULMONARY FIBROSIS
    WESTCOTT, JL
    COLE, SR
    [J]. RADIOLOGY, 1986, 161 (03) : 665 - 669
  • [10] Epithelial dysplasia and lung cancer in end-stage idiopathic pulmonary fibrosis: Padova experience
    Nannini, N.
    Lunardi, F.
    Balestro, E.
    Rossi, E.
    Loy, M.
    Saetta, M.
    Rea, F.
    Calabrese, F.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S54 - S54